ASNB EKIMAS
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.
Company profile
Ticker
ASNB
Exchange
Website
CEO
Michael F. Adams
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Boston Scientific • Baxter International • Becton, Dickinson And • 3M • Stryker • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...
Former names
AdvanSource Biomaterials Corp, CARDIOTECH INTERNATIONAL INC
SEC CIK
Corporate docs
IRS number
43186647
ASNB stock data
()
Calendar
1 Apr 20
11 Apr 21
31 Mar 22
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Dec 19 | Khristine L Carroll | Common Stock | Aquire X | No | No | 0 | 600,000 | 0 | 1,335,309 | |
5 Dec 19 | Khristine L Carroll | Common Stock | Aquire X | No | No | 0 | 350,000 | 0 | 735,309 | |
5 Dec 19 | Khristine L Carroll | Common Stock | Aquire X | No | No | 0.06 | 100,000 | 6K | 385,309 | |
5 Dec 19 | Michael L Barretti | Common Stock | Aquire X | No | No | 0.06 | 25,000 | 1.5K | 550,115 | |
5 Dec 19 | William J Oneill JR | Common Stock | Aquire X | No | No | 0.06 | 25,000 | 1.5K | 550,000 | |
5 Dec 19 | Mark R Tauscher | Common Stock | Aquire X | No | No | 0 | 350,000 | 0 | 400,000 | |
5 Dec 19 | Mark R Tauscher | Common Stock | Aquire X | No | No | 0.06 | 50,000 | 3K | 50,000 | |
5 Dec 19 | Michael L Barretti | Common Stock | Aquire X | No | No | 0 | 525,000 | 0 | 525,115 |
Institutional ownership Q3 2019
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
13F holders |
Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares |
Current |
---|---|
Total value | 0 |
Total shares | 0 |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners |
Shares | Value |
---|
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
acquire, acquiree, acquirer, add, arrangement, assigned, binding, calendar, ceased, Chemical, commenced, consummation, contingent, declare, Delaware, department, desiring, disbursed, discontinued, disposition, distribution, entity, extinguishment, fairly, firm, gain, inability, industry, insurance, intangible, intellectual, investigated, January, kind, lack, lieu, maintenance, MCPP, merge, merger, Mitsubishi, newly, ninety, opportunity, owner, payroll, phase, prepaid, proven, purpose, reach, reclassified, relieved, requisite, restrict, retention, seeking, segment, seller, slight, stage, suitable, sustained
Removed:
acceptable, acceptance, accomplishing, adequate, adjustment, afford, alleviated, analyzed, animal, antibiotic, antimicrobial, ASC, assured, bacterial, bear, behalf, billed, biocompatibility, biodurable, biomaterial, body, Bulletin, catastrophic, ChronoFilm, ChronoFlex, ChronoPrene, ChronoSil, ChronoThane, clinical, clot, Codification, collected, combined, complex, compliant, component, consistent, contract, Conventional, copolymer, Council, cracking, created, custom, customary, customize, debt, Decision, degradation, degree, delay, delivery, demanding, depreciation, determinable, dimensional, distinct, drug, ease, edge, elastic, elasticity, elastomer, eliminate, embodied, enabling, enforce, engineering, environment, environmental, European, exclusive, exclusivity, executed, exist, expand, expanding, expensed, expertise, extent, failure, family, feel, field, fixed, flow, focused, formulation, fulfill, functional, generate, generated, goal, graft, heightened, hospital, hydrated, HydroMed, hydrophilic, HydroThane, implantable, improve, incorporation, increasing, incurred, infection, infringed, inherent, insertion, invasive, investing, jointly, laboratory, leading, legacy, lesser, licensing, living, lower, lubricity, manufacturability, manufacture, marketplace, mechanical, modified, notably, obtain, occur, offered, Office, optional, oral, order, overcome, overcoming, overhead, pacemaker, patent, patented, penetration, perpetual, physical, point, PolyBlend, PolyMedica, polymerization, polyurethane, positive, possessing, practice, processing, production, proprietary, protect, protection, provisional, recognize, registrant, remeasurement, resistance, resolved, resulting, retrospective, return, SAB, satisfying, science, secure, separate, shipment, single, smooth, specialty, specific, Specifically, spongiform, stability, stated, sublicense, successful, suited, supplied, supply, tailored, technology, thermoplastic, tissue, title, trade, trademark, transferred, transmissible, typically, unforeseen, unique, unrelated, utility, utilize, variety, vascular, vigorously, waste, wide, working, written
Financial reports
10-Q
2020 Q3
Quarterly report
1 Apr 20
NT 10-Q
Notice of late quarterly filing
18 Feb 20
10-Q
2020 Q2
Quarterly report
13 Nov 19
10-Q
2020 Q1
Quarterly report
30 Sep 19
10-K/A
2019 FY
Annual report (amended)
23 Aug 19
10-K
2019 FY
Annual report
22 Aug 19
NT 10-Q
Notice of late quarterly filing
14 Aug 19
NT 10-K
Notice of late annual filing
1 Jul 19
10-Q
2019 Q3
Quarterly report
19 Feb 19
NT 10-Q
Notice of late quarterly filing
13 Feb 19
Current reports
8-K
Departure of Directors or Certain Officers
13 Oct 20
8-K
Other Events
28 Jun 20
8-K
EKIMAS Corporation Announces Special Cash Distribution
6 Apr 20
8-K
Amendments to Articles of Incorporation or Bylaws
3 Apr 20
8-K
Completion of Acquisition or Disposition of Assets
6 Feb 20
8-K
Submission of Matters to a Vote of Security Holders
24 Jan 20
8-K
Entry into a Material Definitive Agreement
2 Dec 19
8-K
Other Events
25 Nov 19
8-K
Departure of Directors or Certain Officers
21 Aug 17
8-K
Changes in Registrant's Certifying Accountant
2 Feb 16
Registration and prospectus
25-NSE
Exchange delisting
5 Dec 10
S-8
Registration of securities for employees
21 Feb 08
S-8
Registration of securities for employees
21 Feb 08
S-8
Registration of securities for employees
21 Feb 08
424B3
Prospectus supplement
9 Feb 06
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 06
POS AM
Prospectus update (post-effective amendment)
29 Jan 06
RW
Registration withdrawal request
11 May 05
S-1/A
IPO registration (amended)
8 May 05
S-1
IPO registration
24 Apr 05
Proxies
DEFM14A
Proxy related to merger
30 Dec 19
PREM14A
Preliminary proxy related to merger
17 Dec 19
DEFA14A
Additional proxy soliciting materials
2 Dec 19
DEFA14A
Additional proxy soliciting materials
25 Nov 19
DEF 14A
Definitive proxy
28 Jul 11
DEF 14A
Definitive proxy
27 Jul 10
DEF 14A
Definitive proxy
30 Aug 09
DEF 14A
Definitive proxy
26 Aug 08
PRE 14A
Preliminary proxy
13 Aug 08
DEF 14A
Definitive proxy
29 Aug 07
Ownership
SC 13D
AdvanSource Biomaterials Corp
18 Dec 19
4
AdvanSource Biomaterials / Khristine L Carroll ownership change
6 Dec 19
4
AdvanSource Biomaterials / MICHAEL L BARRETTI ownership change
6 Dec 19
4
AdvanSource Biomaterials / WILLIAM J ONEILL JR ownership change
6 Dec 19
4
AdvanSource Biomaterials / MARK R TAUSCHER ownership change
6 Dec 19
4
AdvanSource Biomaterials / MICHAEL L BARRETTI ownership change
6 Dec 19
4
AdvanSource Biomaterials / WILLIAM J ONEILL JR ownership change
6 Dec 19
4
AdvanSource Biomaterials / MICHAEL F ADAMS ownership change
6 Dec 19
4
AdvanSource Biomaterials / Khristine L Carroll ownership change
19 Aug 18
4
AdvanSource Biomaterials / Khristine L Carroll ownership change
31 Aug 17